rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
In the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-R...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/12/2234 |
_version_ | 1828164612077387776 |
---|---|
author | Yuanyuan Zheng Li Lv Longda Yi Rui Wu Rong Xiao Jihong Wang |
author_facet | Yuanyuan Zheng Li Lv Longda Yi Rui Wu Rong Xiao Jihong Wang |
author_sort | Yuanyuan Zheng |
collection | DOAJ |
description | In the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-RGD3 could also suppress the tumor growth in HeyA8 xenografted mice has not been reported yet. In the present study, rLj-RGD3 was intraperitoneally injected in the nude mice bearing HeyA8 tumors. Compared with the control group (normal saline), rLj-RGD3 inhibited the tumor growth significantly in the HeyA8 xenografted mice in a dose-dependent manner without affecting their body weights. Based on the H&E, Hoechst 33258 and TUNEL staining assays, as well as western blot analysis, rLj-RGD3 reduced the weight and volume of the solid tumors, probably by disturbing the tissue structure, inducing apoptosis and suppressing the FAK/PI3K/AKT pathway. Most importantly, rLj-RGD3 was found to prolong the survival days of the ovarian tumor xenografted mice, which suggested rLj-RGD3 might act as an effective and safe drug to treat ovarian cancer patients. |
first_indexed | 2024-04-12T01:30:27Z |
format | Article |
id | doaj.art-291b6210738d4b76a57327ec125e097f |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-04-12T01:30:27Z |
publishDate | 2017-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-291b6210738d4b76a57327ec125e097f2022-12-22T03:53:31ZengMDPI AGMolecules1420-30492017-12-012212223410.3390/molecules22122234molecules22122234rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude MiceYuanyuan Zheng0Li Lv1Longda Yi2Rui Wu3Rong Xiao4Jihong Wang5School of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaDepartment of Pharmacology, Dalian Medical University, Dalian 116044, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaIn the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-RGD3 could also suppress the tumor growth in HeyA8 xenografted mice has not been reported yet. In the present study, rLj-RGD3 was intraperitoneally injected in the nude mice bearing HeyA8 tumors. Compared with the control group (normal saline), rLj-RGD3 inhibited the tumor growth significantly in the HeyA8 xenografted mice in a dose-dependent manner without affecting their body weights. Based on the H&E, Hoechst 33258 and TUNEL staining assays, as well as western blot analysis, rLj-RGD3 reduced the weight and volume of the solid tumors, probably by disturbing the tissue structure, inducing apoptosis and suppressing the FAK/PI3K/AKT pathway. Most importantly, rLj-RGD3 was found to prolong the survival days of the ovarian tumor xenografted mice, which suggested rLj-RGD3 might act as an effective and safe drug to treat ovarian cancer patients.https://www.mdpi.com/1420-3049/22/12/2234rLj-RGD3HeyA8 cellsnude micePI3KAKT |
spellingShingle | Yuanyuan Zheng Li Lv Longda Yi Rui Wu Rong Xiao Jihong Wang rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice Molecules rLj-RGD3 HeyA8 cells nude mice PI3K AKT |
title | rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice |
title_full | rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice |
title_fullStr | rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice |
title_full_unstemmed | rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice |
title_short | rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice |
title_sort | rlj rgd3 suppresses the growth of heya8 cells in nude mice |
topic | rLj-RGD3 HeyA8 cells nude mice PI3K AKT |
url | https://www.mdpi.com/1420-3049/22/12/2234 |
work_keys_str_mv | AT yuanyuanzheng rljrgd3suppressesthegrowthofheya8cellsinnudemice AT lilv rljrgd3suppressesthegrowthofheya8cellsinnudemice AT longdayi rljrgd3suppressesthegrowthofheya8cellsinnudemice AT ruiwu rljrgd3suppressesthegrowthofheya8cellsinnudemice AT rongxiao rljrgd3suppressesthegrowthofheya8cellsinnudemice AT jihongwang rljrgd3suppressesthegrowthofheya8cellsinnudemice |